ERIC SMITH: Open Payments
NPI 1790206829 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,958 in 121 payments from 16 companies in 2025. Trend: 2023 $1,667 · 2024 $1,393 · 2025 $1,958
Food & beverage: $1,886Education: $73
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 49 | $694 |
| Alkermes, Inc. | 14 | $237 |
| Vanda Pharmaceuticals Inc. | 9 | $192 |
| E.R. Squibb & Sons, L.L.C. | 13 | $160 |
| Otsuka America Pharmaceutical, Inc. | 10 | $137 |
| Neurocrine BioSciences, Inc. | 7 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| ABBVIE INC. | 3 | $64 |
| Sage Therapeutics, LLC | 2 | $53 |
| Axsome Therapeutics, Inc. | 3 | $50 |
Products named: UZEDY, AUSTEDO XR, ARISTADA, FANAPT, COBENFY, REXULTI, INGREZZA, CAPLYTA.
Industry payments across PA — which companies pay providers there.
